{"id":79239,"date":"2018-06-02T13:23:13","date_gmt":"2018-06-02T20:23:13","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2018\/06\/prostate-cancer-breakthrough-as-new-drug-keeps-men-with-previously-untreatable-cases-alive"},"modified":"2018-06-02T13:23:13","modified_gmt":"2018-06-02T20:23:13","slug":"prostate-cancer-breakthrough-as-new-drug-keeps-men-with-previously-untreatable-cases-alive","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2018\/06\/prostate-cancer-breakthrough-as-new-drug-keeps-men-with-previously-untreatable-cases-alive","title":{"rendered":"Prostate cancer breakthrough as new drug keeps men with previously \u2018untreatable\u2019 cases alive"},"content":{"rendered":"<p>M en with <a href=\"https:\/\/www.telegraph.co.uk\/prostate-cancer\/\">previously \u201cuntreatable\u201d prostate cancer<\/a> are being kept alive by a new drug in what experts believe may be a breakthrough for patients with the worst form of the disease.<\/p>\n<p>A British trial has for the first time shown that state-of-the art immunotherapy can be used to target prostate tumours.<\/p>\n<p>The study at the Royal Marsden Hospital in London found more than a third of men who had run out of existing options were still alive and one in ten had not seen their tumours grow after a year of taking Pembrolizumab, which targets a gateway helps the immune system to attack cancer cells.<\/p>\n<p><!-- Link: <a href=\"https:\/\/www.telegraph.co.uk\/news\/2018\/06\/02\/prostate-cancer-breakthrough-new-drug-keeps-men-previously-untreatable\/\">https:\/\/www.telegraph.co.uk\/news\/2018\/06\/02\/prostate-cancer-...treatable\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>M en with previously \u201cuntreatable\u201d prostate cancer are being kept alive by a new drug in what experts believe may be a breakthrough for patients with the worst form of the disease. A British trial has for the first time shown that state-of-the art immunotherapy can be used to target prostate tumours. The study at [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1522],"tags":[],"class_list":["post-79239","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-innovation"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/79239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=79239"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/79239\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=79239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=79239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=79239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}